Table 1:

Lateralization of regional ADC and FA in patients with NF-1 and healthy volunteers (mean ± SD and significance of difference)

ROI and HemispherePatients with NF-1Healthy Volunteers
ADCP(R vs L)FAP(R vs L)ADCP(R vs L)FAP(R vs L)
Caudate nucleus
    R0.94 ± 0.02.0060.13 ± 0.02.0560.78 ± 0.02.5390.18 ± 0.00.596
    L0.96 ± 0.030.12 ± 0.020.79 ± 0.030.18 ± 0.00
Lentiform Nucleus
    R0.95 ± 0.02.0860.10 ± 0.01.1600.76 ± 0.03.3020.14 ± 0.01.063
    L0.97 ± 0.020.10 ± 0.010.76 ± 0.020.15 ± 0.01
Thalamus
    R0.99 ± 0.03.0330.19 ± 0.02.6830.77 ± 0.02.7030.28 ± 0.01.719
    L0.98 ± 0.020.19 ± 0.020.77 ± 0.020.28 ± 0.01
Frontal WM
    R0.95 ± 0.02.00020.26 ± 0.04.9060.79 ± 0.04.3550.34 ± 0.01.098
    L0.99 ± 0.020.26 ± 0.060.80 ± 0.030.37 ± 0.01
Parietooccipital WM
    R0.96 ± 0.04.0090.36 ± 0.04.0260.77 ± 0.03.6170.48 ± 0.02.111
    L0.93 ± 0.030.33 ± 0.050.76 ± 0.030.45 ± 0.02
  • Note:—ADC indicates apparent diffusion coefficient; FA, fractional anisotropy; NF-1, neurofibromatosis type 1; ROI, region of interest; WM: white matter; R, right; L, left.